PARNAXLAB logo

Parnax LAB LTD.

PARNAXLAB·BSE·
134.80 -0.74 (-0.55%)
Market Cap108.88 Cr
PE Ratio13.44
Volume736
Day High - Low135.54 - 130.00
52W High-Low144.95 - 108.03
DocStoX Score
6.6/10
Fair
Fair Value
Sign in to see
ROE
14.40%
Average
P/E
13.44x
Cheap
Debt / Equity
0.87
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day130.00
135.54
52W108.03
144.95
DocStoX take

Supported by valuation (8.0) and momentum (7.5), but weakest on quality (5.4).

DocStoX score

Low confidence
6.6
/10
Fair
Quality
Solid
ROE 14.4%
Valuation
Cheap
P/E 13.4×
Growth
Steady
Revenue +22.5% 5Y CAGR
Risk
Moderate
D/E 0.87
Momentum
Strong
73% of 52-week range

At a glance

Market Cap
₹109 Cr
52W High / Low
₹145 / ₹108
Dividend Yield
0.00%
Promoter Holding
72.30%
EPS (TTM)
₹10.03
Book Value
₹82.83

Key highlights

  • Profitable in all of the last 5 years
  • Undemanding at 13× earnings
  • Revenue compounding 23% a year
  • Small ₹109 cr company — thinner liquidity
3 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

PARNAX LAB LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.